Antibiotics Market by Product, Route Of Administration, and Geography - Forecast and Analysis 2023-2027

Published: Dec 2022 Pages: 163 SKU: IRTNTR41323

Antibiotics Market Analysis Report 2023-2027: 


The antibiotics market size is estimated to grow at a CAGR of 6.07% between 2022 and 2027. The antibiotics market size is forecast to increase by USD 17,066.66 million. The growth of the market depends on several factors, including the rising prevalence of infectious diseases, the growing awareness of various diseases and their treatment, and special regulatory designations. 

This market report extensively covers market segmentation by product (broad-spectrum antibiotics and narrow-spectrum antibiotics), route of administration (intravenous, oral, and others), and geography (Asia, North America, Europe, and Rest of World). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the size of the Antibiotics Market During the Forecast Period?

To learn more about this report, View Report Sample

Antibiotics Market: Key Drivers, Trends, Challenges, and Customer Landscape

The rising prevalence of infectious diseases is notably driving the market growth, although factors such as the development of antibiotic-resistant strains may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Antibiotics Market Driver

The rising prevalence of infectious diseases is notably driving the market growth. Globally, there has been an increase in the number of individuals affected by infectious diseases. Infectious diseases are caused by pathogens and can be transmitted from one person to another through direct or indirect contact. Thus, factors that favor the growth and transmission of these pathogens contribute to the spread of infectious diseases.

Demographic changes caused by increased globalization and urbanization are major factors leading to the global emergence of infectious diseases. Urbanization has led to the overcrowding of human inhabitants. High population densities in these areas favor the colonization of disease pathogens and their persistence in human populations. The expansion of human cities has negatively affected our ecosystems and natural landscapes. For instance, deforestation destroys the natural habitats of animals, which now localize near human habitats. Often these animals are vectors for pathogen transmission, and thus, their movement near human habitats also poses a risk of infection transmission to humans.

The growing number of dams, poor living conditions, lack of sanitation, and inadequate waste management systems are some of the other factors that have increased the incidence and prevalence of diseases. In addition, the changes in environmental conditions and the growing trade and travel are contributing to the increase in the occurrence of infectious diseases among people. Therefore, such factors are estimated to drive the market during the forecast period. 

Significant Antibiotics Market Trends

Strategic alliances and mergers and acquisitions (M&A) are major trends in the market. The formation of strategic alliances, in terms of licensing and collaboration, helps in the co-development and commercialization of drugs in different regions. Co-development agreements between different companies enable the use of technical expertise from both companies. These agreements also allow the use of regulatory and development experience gained by one company for the support of pipeline candidates of another company. Such agreements ensure the inflow of adequate funds from both companies and help to reduce liability costs for individual companies in case of failures and attract more venture investments.

M&A is usually intended to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company. Such a deal agreement allows greater exposure of the drug in different regions. Such agreements enable the complete development of the drugs and provide co-development and commercialization rights for the drugs in different regions. One of the examples of M&A that happened in the market is, Bayer acquired Asklepios BioPharmaceutical to broaden the innovation base in cell and gene therapy. Such factors will help the market expansion during the forecast period. 

Major Antibiotics Market Challenge

The development of antibiotic-resistant strains is a major challenge impeding the market growth. The development of multidrug-resistant microbes is one of the major threats to human health in the present day. The microbe changes itself to protect against the antimicrobial agent used and thereby develops resistance to the drug.

Antibiotic resistance usually develops due to the irrational use of these drugs. The wrong prescription of the drugs by the physicians or the incorrect dosing or course taken by the individual due to lack of awareness, along with the rampant use of these drugs in livestock, poultry, and other animal husbandry industries, has led to the development of antibiotic-resistant strains of microorganism. This occurs because of the increased accumulation of drugs in the body. The commonly used antibiotic drugs thus become ineffective against the microbes, leading to aggravation of the disease in the body. The development of multidrug-resistant variants is acting as a challenge to the market growth, as the drugs available in the market do not show any efficacy in the treatment of these infections, thus decreasing the acceptance of these substances. This will hamper the focused market growth during the forecast period. 

Key Antibiotics Market Customer Landscape

The market  report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Antibiotics Market Customer Landscape

Who are the Major Antibiotics Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories - The company operates under multiple segments including medical devices, and nutritional products with a high focus on medical devices. The company under this segment?offers products for rhythm management, electrophysiology, heart failure, vascular, structural heart, and neuromodulation. The company's key offerings include ACITROM antibiotics.

The antibiotics market report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

  • AbbVie Inc.
  • Armata Pharmaceuticals Inc.
  • Aspen Pharmacare Holdings Ltd
  • Astellas Pharma Inc.
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • F. Hoffmann La Roche Ltd.
  • Flynn Pharma Ltd.
  • GlaxoSmithKline Plc
  • Incepta Pharmaceuticals Ltd.
  • Johnson and Johnson
  • Lupin Ltd.
  • Mayne Pharma Group Ltd.
  • Melinta Therapeutics LLC
  • Merck KGaA

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Antibiotics Market?

The market share growth by the broad-spectrum antibiotics segment will be significant during the forecast period. Broad-spectrum antibiotics are agents that are effective against a wide range of microorganisms, including Gram-positive and Gram-negative agents.

Get a glance at the market contribution of various segments View PDF Sample

The broad-spectrum antibiotics segment shows a gradual increase in the market share of USD 31,706.25 million in 2017 and continued to grow until 2021.  These agents can be used in cases where bacteria do not respond to narrow-spectrum drugs or in cases of serious illness where the infecting agent is not identified, or in cases where multiple bacteria are resulting in the infection. However, the increased use of these agents leads to the development of antibiotic drug resistance. The high market share is attributed to the wide spectrum of activities of these drugs against various microorganisms, making broad-spectrum antibiotics a better option for the treatment of various infections. This can be used as early as the diagnosis or symptoms of any bacterial infection appear before the identification of the disease-causing pathogen. The market is growing due to the rising prevalence of bacterial infections in the sub-economical parts of the underdeveloped and developing regions, where there is improper sanitation, a poor lifestyle of living, and improper disposal of waste, which leads to an increase in bacterial infections, thus increasing the demand for these drugs, thereby driving the market growth. 

Which are the Key Regions for the Antibiotics Market?

For more insights on the market share of various regions View PDF Sample now!

Asia is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The market in this region is expected to grow rapidly during the forecast period, owing to the increasing demand for improved healthcare infrastructure in this region. In addition, the aging population is expected to play a role in increasing market share. The immune system of the geriatric population is vulnerable, thus making them prone to infections. Therefore, an increase in the aging population, along with the development of healthcare infrastructure, is expected to boost the growth of the market.

The market is expected to grow at a moderate rate due to the increasing healthcare spending in the region. Countries such as China and India are expected to show growth opportunities in the future. This can be attributed to healthcare investments by governments and increasing spending by individuals on healthcare. In addition to this, the irrational use of these chemicals is leading to an increase in the development of drug-resistant bacteria, thereby creating an immense need for the use of broad-spectrum antibiotics. There is a growing awareness among physicians about these drugs, which brings substantial growth opportunities. The transformation of the regulatory landscape in Japan encourages vendors to undertake strategic expansions in the country, thereby driving the market growth.

In 2020, the outbreak of COVID-19 compelled governments of various countries to impose lockdowns in the region for several months. This negatively affected the business and economic activities. However, in 2020, due to large-scale vaccination drives, the regional market in focus resumed with the lifting of lockdown restrictions. Thus, the growth of the regional market is expected to stabilize during the forecast period, with the containment of the COVID-19 pandemic. Also, the growing concern about infectious diseases among people is expected to drive the growth of the market in the region during the forecast period.

Segment Overview

The antibiotics market size report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. The market has been segmented by Product (Broad-spectrum antibiotics and Narrow-spectrum antibiotics), Route Of Administration (Intravenous, Oral, and Others), and Geography (Asia, North America, Europe, and Rest of World (ROW)).

  • Product Outlook (USD Million, 2017 - 2027)
    • Broad-spectrum antibiotics
    • Narrow-spectrum antibiotics
  •  Route Of Administration Outlook (USD Million, 2017 - 2027)
    • Intravenous
    • Oral
    • Others
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
      • Vietnam
      • Thailand
      • Indonesia
      • Others
    • Rest of World
      • Saudi Arabia
      • South Africa
      • Brazil
      • Argentina
      • Chile
      • Others

Antibiotics Market Scope

Report Coverage

Details

Page number

163

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 6.07%

Market growth 2023-2027

USD 17,066.66 million

Market structure

Fragmented

YoY growth 2022-2023(%)

5.11

Regional analysis

Asia, North America, Europe, and Rest of World (ROW)

Performing market contribution

Asia at 41%

Key countries

US, UK, China, India, and Japan

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, AbbVie Inc., Armata Pharmaceuticals Inc., Aspen Pharmacare Holdings Ltd, Astellas Pharma Inc., Aurobindo Pharma Ltd., Bayer AG, F. Hoffmann La Roche Ltd., Flynn Pharma Ltd., GlaxoSmithKline Plc, Incepta Pharmaceuticals Ltd., Johnson and Johnson, Lupin Ltd., Mayne Pharma Group Ltd., Melinta Therapeutics LLC, Merck KGaA, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Get access to Report Sample PDF !

What are the Key Data Covered in this Antibiotics Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the antibiotics market between 2023 and 2027
  • Precise estimation of the antibiotics market size and its contribution to the market in focus on the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the industry across Asia, North America, Europe, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of antibiotics market vendors

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global antibiotics market 2022 - 2027
      • Exhibit 18: Historic Market Size – Data Table on Global antibiotics market 2022 - 2027 ($ million)
    • 4.2 Product Segment Analysis 2022 - 2027
      • Exhibit 19: Historic Market Size – Product Segment 2022 - 2027 ($ million)
    • 4.3 Route of administration Segment Analysis 2022 - 2027
      • Exhibit 20: Historic Market Size – Route of administration Segment 2022 - 2027 ($ million)
    • 4.4 Geography Segment Analysis 2022 - 2027
      • Exhibit 21: Historic Market Size – Geography Segment 2022 - 2027 ($ million)
    • 4.5 Country Segment Analysis 2022 - 2027
      • Exhibit 22: Historic Market Size – Country Segment 2022 - 2027 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Broad-spectrum antibiotics - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Broad-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Broad-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Broad-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Broad-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
    • 6.4 Narrow-spectrum antibiotics - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Narrow-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Narrow-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Narrow-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Narrow-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ million)

    7 Market Segmentation by Route of Administration

    • 7.1 Market segments
      • Exhibit 43: Chart on Route of Administration - Market share 2022-2027 (%)
      • Exhibit 44: Data Table on Route of Administration - Market share 2022-2027 (%)
    • 7.2 Comparison by Route of Administration
      • Exhibit 45: Chart on Comparison by Route of Administration
      • Exhibit 46: Data Table on Comparison by Route of Administration
    • 7.3 Intravenous - Market size and forecast 2022-2027
      • Exhibit 47: Chart on Intravenous - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Data Table on Intravenous - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Chart on Intravenous - Year-over-year growth 2022-2027 (%)
      • Exhibit 50: Data Table on Intravenous - Year-over-year growth 2022-2027 (%)
    • 7.4 Oral - Market size and forecast 2022-2027
      • Exhibit 51: Chart on Oral - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Chart on Oral - Year-over-year growth 2022-2027 (%)
      • Exhibit 54: Data Table on Oral - Year-over-year growth 2022-2027 (%)
    • 7.5 Others - Market size and forecast 2022-2027
      • Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by Route of Administration
      • Exhibit 59: Market opportunity by Route of Administration ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 61: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 63: Chart on Geographic comparison
      • Exhibit 64: Data Table on Geographic comparison
    • 9.3 Asia - Market size and forecast 2022-2027
      • Exhibit 65: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 67: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 68: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.4 North America - Market size and forecast 2022-2027
      • Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.5 Europe - Market size and forecast 2022-2027
      • Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 China - Market size and forecast 2022-2027
      • Exhibit 85: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.9 India - Market size and forecast 2022-2027
      • Exhibit 89: Chart on India - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Data Table on India - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Chart on India - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on India - Year-over-year growth 2022-2027 (%)
    • 9.10 UK - Market size and forecast 2022-2027
      • Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.11 Japan - Market size and forecast 2022-2027
      • Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 101: Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 102: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 104: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 105: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 106: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 107: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 108: Abbott Laboratories - Overview
              • Exhibit 109: Abbott Laboratories - Business segments
              • Exhibit 110: Abbott Laboratories - Key news
              • Exhibit 111: Abbott Laboratories - Key offerings
              • Exhibit 112: Abbott Laboratories - Segment focus
            • 12.4 AbbVie Inc.
              • Exhibit 113: AbbVie Inc. - Overview
              • Exhibit 114: AbbVie Inc. - Product / Service
              • Exhibit 115: AbbVie Inc. - Key news
              • Exhibit 116: AbbVie Inc. - Key offerings
            • 12.5 Aspen Pharmacare Holdings Ltd
              • Exhibit 117: Aspen Pharmacare Holdings Ltd - Overview
              • Exhibit 118: Aspen Pharmacare Holdings Ltd - Business segments
              • Exhibit 119: Aspen Pharmacare Holdings Ltd - Key offerings
              • Exhibit 120: Aspen Pharmacare Holdings Ltd - Segment focus
            • 12.6 Astellas Pharma Inc.
              • Exhibit 121: Astellas Pharma Inc. - Overview
              • Exhibit 122: Astellas Pharma Inc. - Product / Service
              • Exhibit 123: Astellas Pharma Inc. - Key offerings
            • 12.7 Aurobindo Pharma Ltd.
              • Exhibit 124: Aurobindo Pharma Ltd. - Overview
              • Exhibit 125: Aurobindo Pharma Ltd. - Product / Service
              • Exhibit 126: Aurobindo Pharma Ltd. - Key offerings
            • 12.8 Bayer AG
              • Exhibit 127: Bayer AG - Overview
              • Exhibit 128: Bayer AG - Business segments
              • Exhibit 129: Bayer AG - Key offerings
              • Exhibit 130: Bayer AG - Segment focus
            • 12.9 F. Hoffmann La Roche Ltd.
              • Exhibit 131: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 132: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 133: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 134: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 135: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.10 GlaxoSmithKline Plc
              • Exhibit 136: GlaxoSmithKline Plc - Overview
              • Exhibit 137: GlaxoSmithKline Plc - Business segments
              • Exhibit 138: GlaxoSmithKline Plc - Key offerings
              • Exhibit 139: GlaxoSmithKline Plc - Segment focus
            • 12.11 Incepta Pharmaceuticals Ltd.
              • Exhibit 140: Incepta Pharmaceuticals Ltd. - Overview
              • Exhibit 141: Incepta Pharmaceuticals Ltd. - Product / Service
              • Exhibit 142: Incepta Pharmaceuticals Ltd. - Key offerings
            • 12.12 Johnson and Johnson
              • Exhibit 143: Johnson and Johnson - Overview
              • Exhibit 144: Johnson and Johnson - Business segments
              • Exhibit 145: Johnson and Johnson - Key news
              • Exhibit 146: Johnson and Johnson - Key offerings
              • Exhibit 147: Johnson and Johnson - Segment focus
            • 12.13 Lupin Ltd.
              • Exhibit 148: Lupin Ltd. - Overview
              • Exhibit 149: Lupin Ltd. - Product / Service
              • Exhibit 150: Lupin Ltd. - Key news
              • Exhibit 151: Lupin Ltd. - Key offerings
            • 12.14 Mayne Pharma Group Ltd.
              • Exhibit 152: Mayne Pharma Group Ltd. - Overview
              • Exhibit 153: Mayne Pharma Group Ltd. - Business segments
              • Exhibit 154: Mayne Pharma Group Ltd. - Key offerings
              • Exhibit 155: Mayne Pharma Group Ltd. - Segment focus
            • 12.15 Merck KGaA
              • Exhibit 156: Merck KGaA - Overview
              • Exhibit 157: Merck KGaA - Business segments
              • Exhibit 158: Merck KGaA - Key news
              • Exhibit 159: Merck KGaA - Key offerings
              • Exhibit 160: Merck KGaA - Segment focus
            • 12.16 Pfizer Inc.
              • Exhibit 161: Pfizer Inc. - Overview
              • Exhibit 162: Pfizer Inc. - Product / Service
              • Exhibit 163: Pfizer Inc. - Key news
              • Exhibit 164: Pfizer Inc. - Key offerings
            • 12.17 Sanofi SA
              • Exhibit 165: Sanofi SA - Overview
              • Exhibit 166: Sanofi SA - Business segments
              • Exhibit 167: Sanofi SA - Key news
              • Exhibit 168: Sanofi SA - Key offerings
              • Exhibit 169: Sanofi SA - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 170: Inclusions checklist
                • Exhibit 171: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 172: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 173: Research methodology
                • Exhibit 174: Validation techniques employed for market sizing
                • Exhibit 175: Information sources
              • 13.5 List of abbreviations
                • Exhibit 176: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              antibiotics market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis